CTF Life Launches MyWealth Beyond Savings Insurance Plan 
6 Ways to Avoid Hidden Fees When Spending Overseas 
China Chunlai Announces 2026 Interim Results 
FREELANDER 8 Production-Intent Show Model Makes Global Debut: First Complete Look at the Legend Reborn 
How to Sell a Business Without a Broker: New Course Helps Owners Keep More of Their Money Retail Giant Walmart Ranks First in List of Brands Most Likely to be Imitated in Phishing Attempts in Q1 2023
Check Point Research’s latest Brand Phishing Report reveals it is all change at the top…
Tiny Announces Closing of Business Combination Transaction
Victoria, British Columbia–(Newsfile Corp. – April 18, 2023) – Tiny Ltd. (formerly WeCommerce Holdings Ltd.)…
Asia’s insurance leaders to gather at InsureTech Connect Asia in Singapore to discuss the future of insurance
SINGAPORE, Apr 18, 2023 – (ACN Newswire) – The second annual InsureTech Connect Asia will…
Mirantis Continues to Ease the Path for Kubernetes Adoption
Automates technology infrastructure setup and management to reduce complexity and help enterprises AMSTERDAM–(BUSINESS WIRE)–#developers—KUBECON —…
FOX NEWS DIGITAL FINISHES THE FIRST QUARTER OF 2023 AS THE TOP NEWS BRAND WITH MULTIPLATFORM VIEWS AND MINUTES
FOX News Digital Sees 28 Percent Year-Over-Year Growth with Unique Visitors Following Homepage Refresh FOX…
KBRA Publishes Rating Report for Bain Capital Specialty Finance, Inc.
NEW YORK–(BUSINESS WIRE)–#KBRA–On February 22, 2023, KBRA assigned issuer and senior unsecured debt ratings of…
Spexis announces closing of capital commitment of USD 4.5 million from SPRIM Global Investments (SGI) to enable initiation of ColiFin® Phase 3 study
Ad hoc announcement pursuant to Art. 53 LR Funding to enable immediate initiation of the…
Spexis announces closing of capital commitment of USD 4.5 million from SPRIM Global Investments (SGI) to enable initiation of ColiFin® Phase 3 study
Ad hoc announcement pursuant to Art. 53 LR Funding to enable immediate initiation of the…
Clinical data validate pioneering MeMed BV technology improves diagnosis of pediatric patients with fever in the Emergency Department
Clinical data validate pioneering MeMed BV technology improves diagnosis of pediatric patients with fever in…
Clinical data validate pioneering MeMed BV technology improves diagnosis of pediatric patients with fever in the Emergency Department
Clinical data validate pioneering MeMed BV technology improves diagnosis of pediatric patients with fever in…
Basilea provides update on New Drug Application to the US Food and Drug Administration for antibiotic ceftobiprole
Ad hoc announcement pursuant to Art. 53 LR Basel/Allschwil, Switzerland, April 18, 2023 Basilea Pharmaceutica…
Basilea provides update on New Drug Application to the US Food and Drug Administration for antibiotic ceftobiprole
Ad hoc announcement pursuant to Art. 53 LR Basel/Allschwil, Switzerland, April 18, 2023 Basilea Pharmaceutica…
Hyloris announces submission of Maxigesic® IV packaging data requested by the US FDA
Maxigesic® IV product 4 Rows of Maxigesic® IV at a manufacturing facility Additional extractable &…
Hyloris announces submission of Maxigesic® IV packaging data requested by the US FDA
Maxigesic® IV product 4 Rows of Maxigesic® IV at a manufacturing facility Additional extractable &…
argenx Demonstrates Commitment to Redefining Treatment Goals for Generalized Myasthenia Gravis with Multiple Presentations at American Academy of Neurology 2023 Annual Meeting
Amsterdam, the Netherlands – [04/18/2023] argenx SE (Euronext & Nasdaq: ARGX), a global immunology company…
argenx Demonstrates Commitment to Redefining Treatment Goals for Generalized Myasthenia Gravis with Multiple Presentations at American Academy of Neurology 2023 Annual Meeting
Amsterdam, the Netherlands – [04/18/2023] argenx SE (Euronext & Nasdaq: ARGX), a global immunology company…
BioSenic receives key European patent from EPO, for further therapeutic development in cancer, infectious and immune diseases
INSIDE INFORMATION Patent covers the therapeutic use of a new composite formulation of anti-inflammatory compounds…
BioSenic receives key European patent from EPO, for further therapeutic development in cancer, infectious and immune diseases
INSIDE INFORMATION Patent covers the therapeutic use of a new composite formulation of anti-inflammatory compounds…
Sumo Logic Helps Control the Chaos by Enhancing Predictive Analytics for Observability
Predicts variable cloud resource needs during production and managing the reliability of digital services AMSTERDAM,…
Ambassador Labs Demonstrates Strong Business Momentum as Development Teams Seek Tools to Easily Manage Full App Lifecycle Across Kubernetes
Technology innovation and strategic partnerships fuel growth as developers harness the power of cloud native…